Publicaciones en las que colabora con Luis Nombela Franco (42)

2023

  1. Cardiac amyloidosis and left atrial appendage closure. The CAMYLAAC study

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 503-510

  2. Cierre de la orejuela izquierda frente a anticoagulantes orales en FA e implante de stents coronarios. Registro DESAFIO

    REC: Interventional Cardiology, Vol. 5, Núm. 4, pp. 287-296

  3. Iberian experience with PASCAL transcatheter edge-to-edge repair for mitral valve regurgitation

    Revista Espanola de Cardiologia, Vol. 76, Núm. 1, pp. 25-31

  4. Impact of Device Implant Depth After Left Atrial Appendage Occlusion

    JACC. Cardiovascular interventions, Vol. 16, Núm. 17, pp. 2139-2149

  5. Right heart remodelling after bicaval TricValve implantation in patients with severe tricuspid regurgitation

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 5, pp. e450-e452

  6. Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry

    Clinical Research in Cardiology, Vol. 112, Núm. 12, pp. 1790-1799

  7. Transcatheter aortic valve implantation in patients with extra-small aortic annuli

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 4, pp. e340-e351

2022

  1. 6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 13, pp. 1366-1377

  2. Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry

    Clinical Research in Cardiology, Vol. 111, Núm. 11, pp. 1276-1285

  3. Early Discontinuation of Antithrombotic Treatment Following Left Atrial Appendage Closure

    American Journal of Cardiology, Vol. 171, pp. 91-98

  4. Early clinical outcomes after transaxillary versus transfemoral TAVI. Data from the Spanish TAVI registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 479-487

  5. Impact of operatoŕs experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry

    IJC Heart and Vasculature, Vol. 38

  6. Incidence and Predictors of Early Death in Patients Undergoing Percutaneous Left Atrial Appendage Closure

    JACC: Clinical Electrophysiology, Vol. 8, Núm. 9, pp. 1093-1102

  7. Left Atrial Appendage Occlusion in Hereditary Haemorrhagic Telangiectasia Patients (Rendu Osler Syndrome) With Non-Valvular Atrial Fibrillation: Prevention of Cardioembolic Events While Avoiding the Long-Term Risks of Oral Anticoagulation

    Cardiovascular Revascularization Medicine

  8. Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure

    Heart (British Cardiac Society), Vol. 108, Núm. 14, pp. 1098-1106

  9. Predictive Power for Thrombus Detection after Atrial Appendage Closure: Machine Learning vs. Classical Methods

    Journal of Personalized Medicine, Vol. 12, Núm. 9

  10. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588